Research Paper Volume 16, Issue 3 pp 2812—2827
Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer
Figure 9. Chemotherapy drug sensitivity. (A–F) IC50 of several chemotherapy drugs in BC. (A) Alisertib; (B) Buparlisib; (C) Dasatinib; (D) Cisplatin; (E) Sorafenib; (F) EPZ5676.